Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-08-10Clinical Trial Update: Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes [Phase 2, Phase 3]
A Phase 2/3 trial evaluating pulsatile intravenous insulin therapy for Type 1 and Type 2 diabetes was terminated.
-
CLINICAL_TRIALS withdrawal · 2016-08-10Clinical Trial Update: Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating pulsatile intravenous insulin delivery for diabetic neuropathy in patients with type 1 and type 2 diab…
-
CLINICAL_TRIALS withdrawal · 2016-08-05Clinical Trial Update: The Inova Type 2 Diabetes Mellitus Study [NA]
The Inova Type 2 Diabetes Mellitus clinical trial has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-13Clinical Trial Update: Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. [NA]
A clinical trial evaluating a nutritional supplement for people with type 2 diabetes has been withdrawn.
-
EMA withdrawal · 2016-06-08EMA Expired: Avandia (rosiglitazone) — SmithKline Beecham Plc
Expired European marketing authorization for Avandia (rosiglitazone) by SmithKline Beecham Plc, for type 2 diabetes mellitus.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2016-06-08EMA Expired: Avandamet (rosiglitazone;metformin hydrochloride) — SmithKline Beecham Plc
Expired status for Avandamet (rosiglitazone/metformin) indicating it is no longer active in the market in the EMA record.
-
CLINICAL_TRIALS withdrawal · 2016-05-27Clinical Trial Update: Medication in Early Diabetes (MED) Study [Phase 4]
A Phase 4 clinical trial called Medication in Early Diabetes (MED) investigating Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-20Clinical Trial Update: Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice [Phase 4]
A Phase 4 trial evaluating the effect of dapagliflozin on quality of life in patients with type 2 diabetes in real-world practice has been w…
-
CLINICAL_TRIALS withdrawal · 2016-05-17Clinical Trial Update: Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes [Phase 3]
This notice reports the withdrawal of a Phase 3 clinical trial studying a rimonabant and metformin combination for blood sugar control in ad…
-
CLINICAL_TRIALS withdrawal · 2016-04-25Clinical Trial Update: GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice
The Bayer-sponsored clinical trial GLucobay M evaluating safety and effectiveness in adults with type 2 diabetes not well controlled on mono…
-
CLINICAL_TRIALS withdrawal · 2016-04-08Clinical Trial Update: Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes [Phase 1]
Phase 1 trial of collagen scaffolds loaded with human umbilical cord mesenchymal stem cells for erectile function in men with diabetes has b…
-
CLINICAL_TRIALS withdrawal · 2016-03-28Clinical Trial Update: A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial of insulin peglispro (LY2605541) for type 2 diabetes mellitus has been withdrawn.
-
EMA withdrawal · 2016-03-10EMA Lapsed: Paglitaz (pioglitazone hydrochloride) — Krka, d.d., Novo mesto
The EMA indicates that Paglitaz (pioglitazone hydrochloride) by Krka has lapsed, with Type 2 diabetes mellitus as the therapeutic area.
-
CLINICAL_TRIALS withdrawal · 2016-01-11Clinical Trial Update: Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial evaluating albiglutide added to basal-bolus insulin therapy in Type 2 diabetes mellitus was withdrawn from the study.
-
CLINICAL_TRIALS withdrawal · 2015-12-30Clinical Trial Update: Sitagliptin in Prevention of Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial evaluating sitagliptin for the prevention of Type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-11Clinical Trial Update: Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
A sub-study investigating how weight-loss surgery affects diabetes control has been withdrawn, involving gastric bypass and gastric banding …
-
CLINICAL_TRIALS withdrawal · 2015-08-21Clinical Trial Update: Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease [Phase 3]
Phase 3 study of fasiglifam (TAK-875) in adults with type 2 diabetes and cardiovascular disease or risk factors was terminated; results were…
-
CLINICAL_TRIALS withdrawal · 2015-07-27Clinical Trial Update: Duodenal Exclusion for the Treatment of Type 2 Diabetes [NA]
Medtronic-sponsored trial of duodenal exclusion for Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-26Clinical Trial Update: Effect of Lycopene and Isoflavones on Glucose Metabolism [NA]
The clinical trial investigating the effects of lycopene and isoflavones on glucose metabolism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-12Clinical Trial Update: Dyslipidemia in Type 2 Diabetes (0767-034) [Phase 3]
A Phase 3 clinical trial evaluating dyslipidemia in adults with type 2 diabetes (NCT00547274) was terminated.
-
CLINICAL_TRIALS withdrawal · 2015-05-19Clinical Trial Update: Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries [Phase 2]
A Phase 2 trial comparing aliskiren versus hydrochlorothiazide in patients with hypertension and type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-30Clinical Trial Update: Regional Fatty Acid Metabolism in Humans
The Mayo Clinic-sponsored trial NCT00068887 investigating regional fatty acid metabolism in humans has been withdrawn. It concerns Type 2 di…
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking Nutralin [Phase 2]
A Phase 2 placebo-controlled trial evaluating Nutralin for HbA1c change in Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-17Clinical Trial Update: Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 2, Phase 3]
A clinical trial evaluating denagliptin in adults with type 2 diabetes mellitus (Phase 2/3) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-13Clinical Trial Update: Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus [Phase 1]
A Phase 1 clinical trial assessing the effect of pioglitazone on left ventricular diastolic function in type 2 diabetes mellitus was withdra…